<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03615807</url>
  </required_header>
  <id_info>
    <org_study_id>n° 2016-01008</org_study_id>
    <nct_id>NCT03615807</nct_id>
  </id_info>
  <brief_title>Less Infections for the Diabetic Foot</brief_title>
  <official_title>Randomized Study Comparing Different Durations of Antibiotic Treatment for Diabetic Foot Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, unblinded, single-centre study. After eventual surgical debridement
      (not amputation), patients will be randomized to receive 1 of 2 targeted antibiotic regimens,
      in the ratio 1:1.

      For diabetic toe osteomyelitis, the patients will be randomized between a 3 and a 6 week's
      arm, for soft tissue infections between 10 and 20 days. The final assessments used in the
      primary efficacy analysis will be obtained at the test-of-cure (TOC) visit approximately 60
      days after treatment is stopped.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diabetic foot infections (DFI) are frequent and are associated with a high burden of
      morbidity, costs, recurrence risk or new episodes of infections. About two-third of recurrent
      DFI may reveal other microorganisms than in the previous period, suggesting new episodes of
      infection due to the underlying problem, and/or selection by prior antimicrobial therapy.
      Osteomyelitis in the diabetic toe is almost always established by contiguous spread of
      infection from a chronic ulcer. It occurs in up to 15% of patients with a diabetic foot ulcer
      and about 20% of all DFI (and over half of severe infections) involve bone at presentation.
      The severity of a diabetic foot infection is based on the local and systemic signs and
      symptoms of infection and has been categorically defined in the Infectious Disease Society of
      America guidelines for the &quot;Diagnosis and Treatment of Diabetic Foot Infections&quot; (IDSA
      guidelines).

      Knowing the potential for poor outcomes, many clinicians have tended to treat DFIs with a
      long duration of antibiotic therapy, with many side effects, development and spreading of
      antibiotic resistance, and associated costs. Data from recent comparative trials has shown
      that 1-2 weeks is sufficient for most soft tissue infections, and 4 to 6 weeks appears
      adequate in those with (unresected) infected bone. Retrospective reviews over the past two
      decades have demonstrated that about two-thirds of selected patients with diabetic foot
      osteomyelitis can achieve remission with antibiotic therapy alone (i.e., without bone
      resection). One recent randomized trial found that treatment with only antibiotic therapy
      (given for 90 days) gave similar clinical outcomes to treatment with conservative surgery
      (removal only of the infected bone) along with just a short course of antibiotic therapy.
      Another randomized trial compared a 6-week against 12-week course of antibiotic therapy,
      without concomitant surgery, for diabetic foot osteomyelitis and also found similar outcomes.

      Likewise, the optimal antibiotic duration for any skin and soft tissue infection is unknown.
      According to some databases of University of Geneva Hospitals, among 378 skin and soft tissue
      infections in 346, overall cure was achieved in 330 episodes (87%) after a median antibiotic
      administration of 15 days. In multivariate Cox regression analysis, duration of antibiotic
      therapy (HR 1.0, 95%CI 0.96-1.02) did not influence treatment failure among patients with
      positive MRSA carriage.

      Our study intends to optimize the duration of antibiotic therapy in DFI; for skin and soft
      tissue infections as well as for diabetic toe osteomyelitis that is not amputated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 16, 2017</start_date>
  <completion_date type="Actual">March 31, 2020</completion_date>
  <primary_completion_date type="Actual">February 29, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two prospected-randomized protocols</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Experiencing Clinical Failure</measure>
    <time_frame>30-60 days</time_frame>
    <description>Visual and dichotomous evaluation regarding the numbers of clinical recurrence/failure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Experiencing Adverse Events Related to the Antibiotic Therapy</measure>
    <time_frame>30-60 days</time_frame>
    <description>Adverse events related to the antibiotic therapy.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">182</enrollment>
  <condition>Diabetic Foot</condition>
  <arm_group>
    <arm_group_label>Short antibiotic arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 days for soft tissue infections 3 weeks for osteomyelitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard antibiotic arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 days for soft tissue infections 6 weeks for osteomyelitis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical debridement (if needed)</intervention_name>
    <description>Surgical debridement</description>
    <arm_group_label>Short antibiotic arm</arm_group_label>
    <arm_group_label>Standard antibiotic arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Microbiological sampling</intervention_name>
    <description>Microbiological sampling</description>
    <arm_group_label>Short antibiotic arm</arm_group_label>
    <arm_group_label>Standard antibiotic arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Revascularisation (if needed).</intervention_name>
    <description>Revascularisation (if needed).</description>
    <arm_group_label>Short antibiotic arm</arm_group_label>
    <arm_group_label>Standard antibiotic arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Off-loading</intervention_name>
    <description>Off-loading by Special shoes</description>
    <arm_group_label>Short antibiotic arm</arm_group_label>
    <arm_group_label>Standard antibiotic arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Patient's education and instructions</intervention_name>
    <description>Patient's education and instructions by specialized nurses</description>
    <arm_group_label>Short antibiotic arm</arm_group_label>
    <arm_group_label>Standard antibiotic arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Wound debridement</intervention_name>
    <description>Regular wound debridement by specialized nurses</description>
    <arm_group_label>Short antibiotic arm</arm_group_label>
    <arm_group_label>Standard antibiotic arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antibiotic duration</intervention_name>
    <description>Systemic antibiotic duration according to the study arms</description>
    <arm_group_label>Short antibiotic arm</arm_group_label>
    <arm_group_label>Standard antibiotic arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≥ 18

          2. Diabetes mellitus

          3. Diabetic Foot Infections

          4. Surgical intervention to remove all necrotic tissue or tenotomy.

          5. Osteomyelitis limited to bone contact or cortical lesions in X-ray.

        Exclusion Criteria:

          1. Implanted device.

          2. More than 96 hours of systemic antibiotic therapy prior to inclusion

          3. Amputation

          4. Destructive osteomyelitis

          5. Concomitant infections requiring more than 14 days of antibiotic therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ilker Uçkay, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Geneva</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Geneva University Hospitals</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <results_reference>
    <citation>Tone A, Nguyen S, Devemy F, Topolinski H, Valette M, Cazaubiel M, Fayard A, Beltrand É, Lemaire C, Senneville É. Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study. Diabetes Care 2015;38:302-307. Diabetes Care. 2015 Apr;38(4):735. doi: 10.2337/dc15-er04b.</citation>
    <PMID>25805867</PMID>
  </results_reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>January 16, 2017</study_first_submitted>
  <study_first_submitted_qc>July 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2018</study_first_posted>
  <results_first_submitted>April 8, 2020</results_first_submitted>
  <results_first_submitted_qc>May 16, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">June 1, 2020</results_first_posted>
  <last_update_submitted>June 2, 2020</last_update_submitted>
  <last_update_submitted_qc>June 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Ilker Uckay</investigator_full_name>
    <investigator_title>Prof. Dr. med Ilker Uçkay</investigator_title>
  </responsible_party>
  <keyword>diabetic foot infections</keyword>
  <keyword>antibiotic reduction</keyword>
  <keyword>osteomyelitis</keyword>
  <keyword>soft tissue infections</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 2, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/07/NCT03615807/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Short Antibiotic Arm</title>
          <description>10 days for soft tissue infections 3 weeks for osteomyelitis
Surgical debridement (if needed): Surgical debridement
Microbiological sampling: Microbiological sampling
Revascularisation (if needed).: Revascularisation (if needed).
Off-loading: Off-loading by Special shoes
Patient's education and instructions: Patient's education and instructions by specialized nurses
Wound debridement: Regular wound debridement by specialized nurses
Antibiotic duration: Systemic antibiotic duration according to the study arms</description>
        </group>
        <group group_id="P2">
          <title>Standard Antibiotic Arm</title>
          <description>20 days for soft tissue infections 6 weeks for osteomyelitis
Surgical debridement (if needed): Surgical debridement
Microbiological sampling: Microbiological sampling
Revascularisation (if needed).: Revascularisation (if needed).
Off-loading: Off-loading by Special shoes
Patient's education and instructions: Patient's education and instructions by specialized nurses
Wound debridement: Regular wound debridement by specialized nurses
Antibiotic duration: Systemic antibiotic duration according to the study arms</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="91"/>
                <participants group_id="P2" count="91"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="79"/>
                <participants group_id="P2" count="80"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Diabetic foot infections requiring tretement</population>
      <group_list>
        <group group_id="B1">
          <title>Short Antibiotic Arm</title>
          <description>10 days for soft tissue infections 3 weeks for osteomyelitis
Surgical debridement (if needed): Surgical debridement
Microbiological sampling: Microbiological sampling
Revascularisation (if needed).: Revascularisation (if needed).
Off-loading: Off-loading by Special shoes
Patient's education and instructions: Patient's education and instructions by specialized nurses
Wound debridement: Regular wound debridement by specialized nurses
Antibiotic duration: Systemic antibiotic duration according to the study arms</description>
        </group>
        <group group_id="B2">
          <title>Standard Antibiotic Arm</title>
          <description>20 days for soft tissue infections 6 weeks for osteomyelitis
Surgical debridement (if needed): Surgical debridement
Microbiological sampling: Microbiological sampling
Revascularisation (if needed).: Revascularisation (if needed).
Off-loading: Off-loading by Special shoes
Patient's education and instructions: Patient's education and instructions by specialized nurses
Wound debridement: Regular wound debridement by specialized nurses
Antibiotic duration: Systemic antibiotic duration according to the study arms</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="79"/>
            <count group_id="B2" value="80"/>
            <count group_id="B3" value="159"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="65"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70" lower_limit="38" upper_limit="90"/>
                    <measurement group_id="B2" value="67" lower_limit="34" upper_limit="94"/>
                    <measurement group_id="B3" value="68" lower_limit="34" upper_limit="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                    <measurement group_id="B2" value="72"/>
                    <measurement group_id="B3" value="142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="79"/>
                    <measurement group_id="B2" value="80"/>
                    <measurement group_id="B3" value="159"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Switzerland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79"/>
                    <measurement group_id="B2" value="80"/>
                    <measurement group_id="B3" value="159"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Experiencing Clinical Failure</title>
        <description>Visual and dichotomous evaluation regarding the numbers of clinical recurrence/failure</description>
        <time_frame>30-60 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Short Antibiotic Arm</title>
            <description>For soft tissue infection: 10 days of systemic antibiotics For osteomyelitis: 3 weeks</description>
          </group>
          <group group_id="O2">
            <title>Long Antibiotic Arm</title>
            <description>For soft tissue infections: 20 days For osteomyelitis: 6 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Experiencing Clinical Failure</title>
          <description>Visual and dichotomous evaluation regarding the numbers of clinical recurrence/failure</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="79"/>
                <count group_id="O2" value="80"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Experiencing Adverse Events Related to the Antibiotic Therapy</title>
        <description>Adverse events related to the antibiotic therapy.</description>
        <time_frame>30-60 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Short Antibiotic Arm</title>
            <description>For soft tissue infection: 10 days of systemic antibiotics For osteomyelitis: 3 weeks</description>
          </group>
          <group group_id="O2">
            <title>Long Antibiotic Arm</title>
            <description>For soft tissue infections: 20 days For osteomyelitis: 6 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Experiencing Adverse Events Related to the Antibiotic Therapy</title>
          <description>Adverse events related to the antibiotic therapy.</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="79"/>
                <count group_id="O2" value="80"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The adverse events were collected during the first two months of therapy.</time_frame>
      <desc>Adverse Events Definition: Any untoward or unfavorable medical occurrence in a participant, including any abnormal sign (for example, abnormal physical exam or laboratory finding), symptom, or disease, temporally associated with the participant’s participation in the research, whether or not considered related to the participant’s participation in the research.</desc>
      <group_list>
        <group group_id="E1">
          <title>Short Antibiotic Arm</title>
          <description>10 days antibiotic for soft tissue infections 3 weeks antibiotic for osteomyelitis</description>
        </group>
        <group group_id="E2">
          <title>Long Antibiotic Arm</title>
          <description>20 days antibiotic for soft tissue infections 6 weeks antibiotic for osteomyelitis</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="80"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="79"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Progressive ischemia leading to necrosis and amputation</sub_title>
                <description>Progressive ischemia leading to necrosis and amputation</description>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="79"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="79"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Cutaneous rash</sub_title>
                <description>Cutaneous rash</description>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="79"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Professor Ilker UCKAY</name_or_title>
      <organization>Balgrist University Hospital</organization>
      <phone>+41 44 386 37 05</phone>
      <email>ilker.uckay@balgrist.ch</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

